Ms Sharon Heng is a multilingual consultant ophthalmic surgeon with her NHS practice at the world renowned Moorfields Eye Hospital.
她专攻视网膜内科学疾病和白内障。 她现任Moorfields 眼科医院医学视网膜部门主任、该院医学视网膜数字门诊的临床负责人,以及伊灵摩尔菲尔德分院西北糖尿病视网膜病变筛查项目的负责人。邢医生 从事眼科临床工作已逾15年。

邢医生毕业于新加坡国立大学,随后前往英国,在伦敦大学学院眼科研究所,在Professor John Marshall(屈光手术中准分子激光技术的先驱)和Professor 教Sobha Sivaprasad 的指导下,攻读与年龄相关性黄斑变性预防治疗相关的博士学位。她在塞文教区(Severn Deanery)和布里斯托尔眼科医院接受了临床培训,随后回到摩尔菲尔德眼科医院,先后担任临床研究员、顾问医师、临床负责人及主任。
Ms Heng believes strongly in training the next generation of ophthalmologists and allied health professionals and is actively involved in developing teaching modules and programs for education within the NHS and beyond. She has travelled to China to assist in developing education programs for the local doctors. She was also involved in the development of diabetic retinopathy screening program and laser teaching for Chinese Ophthalmologists in China with Professor Peter Scanlon. She is also supervisor to several masters students at the Institute of Ophthalmology , UCL in retina diseases. She has also been chair or speaker for numerous preceptorship programs hosting foreign doctors from Australia, UAE etc and founded the Moorfields Retina Laser Course.
Ms Heng is a co-editor on the Inspire Program (medical retina) by the Royal College of Ophthalmologists and sits an editorial board member of the Eye Journal.
Ms Heng is also active in research and is chief investigator for several clinical studies looking at inequality within the medical retina digital clinics and treatment burden and efficacy across different types of Wet AMD Anti-VEGF treatment to patients and their carers.
She was also involved as principal and sub-investigator of numerous pivotal clinical trials including the 2RT RETILASE study and OZLASE study(one of the first studies to evaluate use of Ozurdex steroid implant in diabetic macular oedema in the UK) in the course of her career.
她已在全球范围内进行了50多次国际学术报告。
Ms Heng currently sits as a steering group committee member for pharmaceutical companies advising on treatment biomarkers and was heavily involved in the publication of the Handbook for ‘Biomarkers in Diabetic Macular Oedema’ with Abbvie Ltd for healthcare professionals. She also sat as an expert advisor for new retina diseases treatment for MHRA (Medicines & Healthcare products Regulatory Agency) in January and July 2026.
邢医生积极参与社区服务,并于2017年至2023年担任新加坡国立大学校友会主席,致力于搭建新加坡民众、校友与英国同仁之间的桥梁。
亨医生通晓英语和普通话,并能理解粤语和闽南语。



邢医生精通英语和普通话,并能理解粤语及闽南语。她致力于确保患者能以最舒适的沟通语言理解自身病情、治疗方案及预后情况。
每次诊疗后,邢医生都会提供书面诊疗摘要,内容涵盖诊断结果、治疗方案、风险及益处。

视网膜疾病常与全身性并发症(如糖尿病、高血压、高胆固醇血症等系统性疾病)相关。她坚信预防胜于治疗,在可行且必要时,会指导患者如何更好地照护自身及视力健康。
邢医生持续关注最新治疗进展、临床试验至真实世界数据,并始终以患者为中心提供个性化治疗方案。

亨女士坚信,应将科学数据、影像学、蛋白质组学、眼科组学及生物标志物整合到诊疗过程中,从而为患者制定最佳的个性化治疗方案,以期最大限度地优化治疗效果。
她担任多个委员会的成员,致力于推动视网膜疾病诊疗的个性化发展。

邢医生因在科学研究与社区服务领域的贡献屡获
殊荣,以下为部分获奖记录:


邢医生坚信回馈社会。她与丈夫定期参与社区活动,致力于提升华裔社群对其所处小圈子及环境的认知。她曾担任新加坡国立大学英国校友会主席(拥有800名会员),并联合委员会创立了一系列专业论坛,探讨社会中复杂而紧迫的议题,为旅英新加坡人搭建交流平台。
邢医生及其家人还积极支持儿童教育事业,并向英国的助学金项目捐款,以资助当地儿童的教育。